B Charbonnel
Impact in
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Nephrology top 1%
Papers in
-
- Diabetes Treatment and Management 99
- Diabetes Management and Research 80
- Diabetes, Cardiovascular Risks, and Lipoproteins 32
- Surgery 57
- Pancreatic function and diabetes 32
- Adrenal and Paraganglionic Tumors 12
- Co-authors
- F. DrayJacques MacloufSteven G. TerraBertrand CariouRichard E. PratleyChristopher P. CannonDarren K. McGuireWeichung Shih
- Journals
- Diabetes & Metabolism (18 papers)Diabetes Obesity and Metabolism (17 papers)The Journal of Clinical Endocrinology & Metabolism (10 papers)Diabetologia (9 papers)Diabetes Care (7 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
B Charbonnel
230 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Endocrinology, Diabetes and Metabolism 7.1k
- Nephrology 470
- Pharmacology 1.1k
- Surgery 2.8k
- Cardiology and Cardiovascular Medicine 1.2k
Countries citing papers authored by B Charbonnel
This map shows the geographic impact of B Charbonnel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Charbonnel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Charbonnel more than expected).
Fields of papers citing papers by B Charbonnel
This network shows the impact of papers produced by B Charbonnel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Charbonnel. The network helps show where B Charbonnel may publish in the future.
Co-authors
The 25 scholars most cited alongside B Charbonnel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 13 | |
| 2 | 2020 | 175 | |
| 3 | 2020 | 7 | |
| 4 | 2018 | 19 | |
| 5 | 2018 | 55 | |
| 6 | 2017 | 1 | |
| 7 | 2017 | 32 | |
| 8 | [Determinants of the cost of initiation of insulin therapy type 2 diabetic patients in France: possible approaches to optimization]. | 2016 | 4 |
| 9 | Abstract 14642: Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose Tolerance? Insights from the NAVIGATOR Study | 2012 | 1 |
| 10 | PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study | 2007 | 14 |
| 11 | Pioglitazone reduces insulin requirements and improves glycaemic control in insulin-treated patients with type 2 diabetes: results from PROactive | 2006 | 5 |
| 12 | Long-term glycaemic effects of pioglitazone in triple oral therapy: Results from PROactive | 2006 | 5 |
| 13 | [SFC/ALFEDIAM (French Cardiology Society/French-speaking Association for the Study of Diabetes and Metabolic Diseases) guidelines on the management of the diabetic patient seen by a cardiologist. Recommendations, rationale, references]. | 2004 | 6 |
| 14 | Which are the insulin treatment regimens used in France? The "Schema survey". | 2001 | 11 |
| 15 | Effets antidiabétiques des thiazolidinediones | 2001 | 2 |
| 16 | Pratique de l'insulinothérapie en France. Résultats de l'enquête « schéma » | 2000 | 1 |
| 17 | [Strategy for patient management with type 2 diabetes excepting care of complications. Recommendations of ANAES--March 2000]. | 2000 | 3 |
| 18 | Multicentre evaluation of the DCA 2000 system for measuring glycated haemoglobin. DCA 2000 Study Group. | 1997 | 25 |
| 19 | Un debut logrado | 1987 | 1 |
| 20 | [Hormone and metabolic profile in diabetic hyperosomolar coma. Plasma insulin response to intravenous tolbutamide (author's transl)]. | 1978 | 2 |
About B Charbonnel
B Charbonnel is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Pharmacology, Genetics and Reproductive Medicine, having authored 240 papers that have together received 9.7k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (99 papers), Diabetes Management and Research (80 papers), Metabolism, Diabetes, and Cancer (61 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (32 papers), Pancreatic function and diabetes (32 papers), Diabetes and associated disorders (27 papers), Pharmacology and Obesity Treatment (12 papers) and Adrenal and Paraganglionic Tumors (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (7.1k citations), Nephrology (470 citations), Pharmacology (1.1k citations), Surgery (2.8k citations) and Cardiology and Cardiovascular Medicine (1.2k citations). B Charbonnel has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include F. Dray, Jacques Maclouf, Steven G. Terra, Bertrand Cariou, Richard E. Pratley, Christopher P. Cannon, Darren K. McGuire, Weichung Shih, Susan Huyck and Francesco Cosentino. Their work appears in journals such as Diabetes & Metabolism, Diabetes Obesity and Metabolism, The Journal of Clinical Endocrinology & Metabolism, Diabetologia and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.